highperformr logo

Coda Biotherapeutics's Overview

Total employees65
HeadquartersSouth San Francisco
Founded2014

Coda Biotherapeutics is a preclinical-stage biopharmaceutical company pioneering a new generation of targeted gene therapies for neurological disorders. They are leveraging their proprietary chemogenetic platform to develop treatments that enable precise, reversible, and titratable control of neuronal activity. Coda's primary focus is on developing therapies for focal epilepsy and neuropathic pain, aiming to provide durable and tunable relief for patients with these debilitating conditions.

Where is Coda Biotherapeutics's Headquarters?

HQ Function

Serves as the central hub for research and development, corporate operations, and strategic planning for its novel gene therapy programs.

Notable Features:

Located within a prominent biotech campus, providing access to state-of-the-art laboratory facilities and a collaborative research environment.

Work Culture:

A dynamic and science-driven environment focused on innovation, collaboration, and addressing unmet medical needs in neurology. Employees are typically passionate about advancing gene therapy and making a difference in patients' lives.

HQ Significance:

Its location in South San Francisco places Coda Biotherapeutics at the epicenter of the biotech industry, fostering collaborations, talent acquisition, and access to a rich ecosystem of research institutions and investors.

Values Reflected in HQ: The headquarters' focus on advanced research facilities underscores the company's commitment to scientific excellence and innovation in gene therapy.

Location:

Coda Biotherapeutics is currently focused on preclinical development and research primarily conducted from its US headquarters. While its therapeutic ambitions have global implications for patients with neurological disorders, its operational presence is concentrated in the United States. Future global expansion may occur as its programs advance through clinical trials and towards commercialization.

Street Address:

611 Gateway Blvd, Suite 215

City:

South San Francisco

State/Province:

CA

Country:

USA

Coda Biotherapeutics's Global Presence

Buying Intent Signals for Coda Biotherapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Coda Biotherapeutics

As of April 2025, Coda Biotherapeutics' leadership includes:

Michael Narachi - President & Chief Executive Officer
Susan Catalano, Ph.D. - Co-founder & Chief Scientific Officer
Starling W. Childs - Chief Operating Officer
Douglas J.J.M. Heitner - Chief Financial Officer
Oranee Daniels, M.D. - Chief Medical Officer
Alexei Degterev, Ph.D. - Senior Vice President, Discovery Biology
John Chen - Senior Vice President, Technical Operations

Investors of Coda Biotherapeutics

Coda Biotherapeutics has been backed by several prominent investors over the years, including:

MPM Capital
Versant Ventures
Longitude Capital
Temasek
Alexandria Venture Investments
Casdin Capital
BioMedPartners
Lightstone Ventures
UCL Technology Fund

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

In the past 12 months, Coda Biotherapeutics strengthened its technical operations leadership with a key SVP hire. No major C-suite departures have been publicly announced during this period.

New Appointments:

John Chen, John Chen was appointed as Senior Vice President, Technical Operations to lead the company's CMC and manufacturing strategies.

Technology (Tech Stack) used by Coda Biotherapeutics

Discover the tools Coda Biotherapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Coda Biotherapeutics Email Formats and Examples

Common email formats for Coda Biotherapeutics likely follow standard professional patterns. One of the most probable formats uses the first initial followed by the last name.

[first_initial][last]@codabio.com

Format

mnarachi@codabio.com

Example

75%

Success rate

News and media

GlobeNewswireNovember 7, 2023

Coda Biotherapeutics Presents Preclinical Data at Society for Neuroscience 2023 Annual Meeting

Coda Biotherapeutics announced the presentation of preclinical data highlighting the potential of its chemogenetic gene therapy platform in selectively and reversibly modulating neuronal activity for neurological disorders. The data were shared at the Society for Neuroscience (SfN) 2023 annual meeting....more

GlobeNewswireMay 17, 2023

Coda Biotherapeutics Presents Positive Preclinical Data from its Gene Therapy Program for Focal Epilepsy at ASGCT 2023 Annual Meeting

Coda Biotherapeutics presented promising preclinical data for its focal epilepsy gene therapy program at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting. The findings demonstrated the potential for durable, titratable seizure control....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Coda Biotherapeutics, are just a search away.